APA

Blain J., Bursavich M. G., Freeman E. A., Hrdlicka L. A., Hodgdon H. E., Chen T., Costa D. E., Harrison B. A., Kapadnis S., Murphy D. A., Nolan S., Tu Z., Tang C., Burnett D. A., Patzke H. & Koenig G. (20171016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. : Alzheimer's research & therapy.

Chicago

Blain Jean-François, Bursavich Matthew G, Freeman Emily A, Hrdlicka Lori A, Hodgdon Hilliary E, Chen Ting, Costa Don E, Harrison Bryce A, Kapadnis Sudarshan, Murphy Deirdre A, Nolan Scott, Tu Zhiming, Tang Cuyue, Burnett Duane A, Patzke Holger and Koenig Gerhard. 20171016. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. : Alzheimer's research & therapy.

Harvard

Blain J., Bursavich M. G., Freeman E. A., Hrdlicka L. A., Hodgdon H. E., Chen T., Costa D. E., Harrison B. A., Kapadnis S., Murphy D. A., Nolan S., Tu Z., Tang C., Burnett D. A., Patzke H. and Koenig G. (20171016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. : Alzheimer's research & therapy.

MLA

Blain Jean-François, Bursavich Matthew G, Freeman Emily A, Hrdlicka Lori A, Hodgdon Hilliary E, Chen Ting, Costa Don E, Harrison Bryce A, Kapadnis Sudarshan, Murphy Deirdre A, Nolan Scott, Tu Zhiming, Tang Cuyue, Burnett Duane A, Patzke Holger and Koenig Gerhard. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. : Alzheimer's research & therapy. 20171016.